BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16002030)

  • 1. Transdermal nicotine alters some of marihuana's effects in male and female volunteers.
    Penetar DM; Kouri EM; Gross MM; McCarthy EM; Rhee CK; Peters EN; Lukas SE
    Drug Alcohol Depend; 2005 Aug; 79(2):211-23. PubMed ID: 16002030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment with transdermal nicotine enhances some of ethanol's acute effects in men.
    Kouri EM; McCarthy EM; Faust AH; Lukas SE
    Drug Alcohol Depend; 2004 Jul; 75(1):55-65. PubMed ID: 15225889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
    Cárdenas L; Busto UE; MacDonald A; Corrigall WA
    Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men.
    Kleykamp BA; Jennings JM; Sams C; Weaver MF; Eissenberg T
    Exp Clin Psychopharmacol; 2008 Apr; 16(2):99-112. PubMed ID: 18489014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of transdermal nicotine on prose memory and attention in smokers and nonsmokers.
    Poltavski DV; Petros T
    Physiol Behav; 2005 Jan; 83(5):833-43. PubMed ID: 15639169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-related cardiovascular and endocrine effects of transdermal nicotine.
    Zevin S; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 1998 Jul; 64(1):87-95. PubMed ID: 9695723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of transdermal nicotine delivery on measures of acute nicotine withdrawal.
    Pickworth WB; Fant RV; Butschky MF; Henningfield JE
    J Pharmacol Exp Ther; 1996 Nov; 279(2):450-6. PubMed ID: 8930145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised double-blind crossover trial of the potential analgesic effect of a transdermal nicotine patch in non-smokers based on objective and subjective assessment.
    Fukada T; Iwakiri H; Ozaki M
    Eur J Anaesthesiol; 2011 Aug; 28(8):592-6. PubMed ID: 21681103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
    Weinstein A; Brickner O; Lerman H; Greemland M; Bloch M; Lester H; Chisin R; Sarne Y; Mechoulam R; Bar-Hamburger R; Freedman N; Even-Sapir E
    J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.
    Hart CL; Ward AS; Haney M; Comer SD; Foltin RW; Fischman MW
    Psychopharmacology (Berl); 2002 Dec; 164(4):407-15. PubMed ID: 12457271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transdermal nicotine patch is not effective for postoperative pain management in smokers: a pilot dose-ranging study.
    Olson LC; Hong D; Conell-Price JS; Cheng S; Flood P
    Anesth Analg; 2009 Dec; 109(6):1987-91. PubMed ID: 19923530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
    Rohsenow DJ; Monti PM; Hutchison KE; Swift RM; MacKinnon SV; Sirota AD; Kaplan GB
    Exp Clin Psychopharmacol; 2007 Feb; 15(1):81-92. PubMed ID: 17295587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers.
    Jones HE; Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 1999 Jan; 288(1):188-97. PubMed ID: 9862770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine intake and dose response when smoking reduced-nicotine content cigarettes.
    Benowitz NL; Jacob P; Herrera B
    Clin Pharmacol Ther; 2006 Dec; 80(6):703-14. PubMed ID: 17178270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nicotine on 35% CO2-induced anxiety: A study in healthy volunteers.
    Cosci F; Abrams K; Schruers KR; Rickelt J; Griez EJ
    Nicotine Tob Res; 2006 Aug; 8(4):511-7. PubMed ID: 16920648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokers.
    Sofuoglu M; Babb D; Hatsukami DK
    Nicotine Tob Res; 2003 Dec; 5(6):947-53. PubMed ID: 14668079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers.
    Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):486-94. PubMed ID: 11160635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of transdermal nicotine on inspection time.
    Thompson JC; Wilby G; Stough C
    Hum Psychopharmacol; 2002 Apr; 17(3):157-61. PubMed ID: 12404693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokers.
    Knott VJ; Fisher DJ
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):368-81. PubMed ID: 17696684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.